Vanda Pharmaceuticals (VNDA) Surges 900% On FDA Approval For its Drug
More News related to VNDA
- Semi-Annual Changes to the NASDAQ Biotechnology Index
- Vanda Pharma (VNDA) Tops by 3c, Posts Q3 Loss of $0.28
- Vanda Pharmaceuticals Reports Third Quarter 2009 Results
- Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
- Vanda (VNDA) and Novartis (NVS) to Develop Fanapt in US and Canada
Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA) is trading at $10 per share in after-hours after the company won approval from the FDA for its schizophrenia drug.
The stock closed at $1.08 today. That's a 900% move higher!
Related Categories
FDAHot List
Momentum Movers
Stocks Mentioned
-0.13Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
vanda
jlm on May 6, 2009 07:24 PMafter hours! so unfair! retail investors left out again.